Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Presti

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of Urology|March 1, 1996
Cost conscious evaluation and treatment of prostate cancerJ Presti
Biochemistry and Molecular Biology International|April 8, 1998
A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancerR Dahiya, G Deng, C Selph, et al.
Seminars in Urologic Oncology|June 30, 2000
Pretreatment prostate-specific antigen and Gleason score predict the risk of extracapsular extension and the risk of failure following radiotherapy in patients with clinically localized prostate cancerM Roach, A Chen, J Song, et al.
British Journal of Urology|May 1, 1995
Differential suppression of serum prostatic acid phosphatase and prostate-specific antigen by 5-alpha-reductase inhibitorP Narayan, A Tewari, G Jacob, et al.
Lancet (London, England)|August 21, 1993
Genetic alterations in bladder cancerG Dalbagni, J Presti, V Reuter, et al.
The British Journal of Surgery|February 4, 2012
Effect of Roux-en-Y gastric bypass on testosterone and prostate-specific antigenG Woodard, S Ahmed, V Podelski, et al.
Cancer|August 5, 1998
Low frequency epithelial cells in bone marrow aspirates from prostate carcinoma patients are cytogenetically aberrantP Mueller, P Carroll, E Bowers, et al.
Neuropharmacology|July 16, 2008
Amelioration of recognition memory impairment associated with iron loading or aging by the type 4-specific phosphodiesterase inhibitor rolipram in ratsM N de Lima, J Presti-Torres, V A Garcia, et al.
The Journal of Urology|August 8, 2001
Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinomaB Grady, R Goharderakhshan, J Chang, et al.
The Journal of Urology|November 1, 1996
Radiotherapy for high grade clinically localized adenocarcinoma of the prostateM Roach, S Meehan, S Kroll, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Urology|March 1, 1996
Cost conscious evaluation and treatment of prostate cancerJ Presti
Biochemistry and Molecular Biology International|April 8, 1998
A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancerR Dahiya, G Deng, C Selph, et al.
Seminars in Urologic Oncology|June 30, 2000
Pretreatment prostate-specific antigen and Gleason score predict the risk of extracapsular extension and the risk of failure following radiotherapy in patients with clinically localized prostate cancerM Roach, A Chen, J Song, et al.
British Journal of Urology|May 1, 1995
Differential suppression of serum prostatic acid phosphatase and prostate-specific antigen by 5-alpha-reductase inhibitorP Narayan, A Tewari, G Jacob, et al.
Lancet (London, England)|August 21, 1993
Genetic alterations in bladder cancerG Dalbagni, J Presti, V Reuter, et al.
The British Journal of Surgery|February 4, 2012
Effect of Roux-en-Y gastric bypass on testosterone and prostate-specific antigenG Woodard, S Ahmed, V Podelski, et al.
Cancer|August 5, 1998
Low frequency epithelial cells in bone marrow aspirates from prostate carcinoma patients are cytogenetically aberrantP Mueller, P Carroll, E Bowers, et al.
Neuropharmacology|July 16, 2008
Amelioration of recognition memory impairment associated with iron loading or aging by the type 4-specific phosphodiesterase inhibitor rolipram in ratsM N de Lima, J Presti-Torres, V A Garcia, et al.
The Journal of Urology|August 8, 2001
Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinomaB Grady, R Goharderakhshan, J Chang, et al.
The Journal of Urology|November 1, 1996
Radiotherapy for high grade clinically localized adenocarcinoma of the prostateM Roach, S Meehan, S Kroll, et al.
Pageof 2